105 related articles for article (PubMed ID: 2825151)
1. Effects of captopril once daily on blood pressure and angiotensin converting enzyme in hypertensive patients.
Rodriguez FJ; Gil V; del Carmen Beneyto M; Lopez-Vidriero E
Postgrad Med J; 1986; 62 Suppl 1():94-6. PubMed ID: 2825151
[TBL] [Abstract][Full Text] [Related]
2. [Diuretic-resistant hypertension. Effect of an additional daily single dose of a ACE inhibitor].
Baumgart P; Tenschert W; Vetter H
Schweiz Med Wochenschr; 1985 Dec; 115(50):1832-4. PubMed ID: 3003892
[TBL] [Abstract][Full Text] [Related]
3. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
[TBL] [Abstract][Full Text] [Related]
4. Effect of captopril on serum angiotensin converting enzyme and blood pressure in hypertensive patients.
Singh R; Kalra OP; Sarma PU; Prabhu KM
J Assoc Physicians India; 1996 Feb; 44(2):109-11. PubMed ID: 10999062
[TBL] [Abstract][Full Text] [Related]
5. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
6. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
Johnson AG; Pearce GL; Danoff TM
J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S
Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620
[TBL] [Abstract][Full Text] [Related]
10. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats.
Ninahuaman MF; Souccar C; Lapa AJ; Lima-Landman MT
Phytomedicine; 2007 May; 14(5):321-7. PubMed ID: 17433647
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the efficacy of captopril and enalapril in single doses in the treatment of arterial hypertension. Evaluation by means of non-invasive ambulatory monitoring].
Valori C; Gambini G; Canini F; Marinelli M; Rossi S; Pinchi G
Clin Ter; 1989 Jul; 130(1):37-44. PubMed ID: 2551565
[TBL] [Abstract][Full Text] [Related]
12. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits.
Chen X; Pitt BR; Moalli R; Gillis CN
J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968
[TBL] [Abstract][Full Text] [Related]
13. [24-hour blood pressure monitoring. Results with captopril once a day].
Puhlmann WH; Strüder P
Fortschr Med; 1990 Nov; 108(34):660-2. PubMed ID: 2289738
[TBL] [Abstract][Full Text] [Related]
14. Crossover comparison of the effects of enalapril and captopril on potassium homeostasis in patients with mild hypertension.
Ohya Y; Ueno M; Takata Y; Tominaga M; Ohmori S; Kobayashi K; Abe I; Fujishima M
Int J Clin Pharmacol Ther; 1994 Dec; 32(12):655-9. PubMed ID: 7881704
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
16. Clinical studies with captopril treatment of hypertensive patients.
Varga K; Alföldi S; Kiss I; Simkó K; Farsang C
Acta Physiol Hung; 1988; 72 Suppl():67-78. PubMed ID: 2855293
[TBL] [Abstract][Full Text] [Related]
17. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
Paran E; Anson O; Neumann L
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the efficacy of captopril at a single daily dose of 100 mg and at a twice daily dose of 50 mg by measuring ambulatory pressure over 24 hours.
De Gaudemaris R; Battistella P; Siche JP; Debru JL; Blatier JF; Mallion JM
Postgrad Med J; 1986; 62 Suppl 1():97-100. PubMed ID: 3534869
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of low dose captopril once daily in diuretic resistant hypertension.
Baumgart P; Tenschert W; Vetter H
Postgrad Med J; 1986; 62 Suppl 1():127-30. PubMed ID: 3534846
[TBL] [Abstract][Full Text] [Related]
20. Effect of cadmium and captopril on serum angiotensin converting enzyme activity in rats.
Puri VN
Indian Heart J; 1997; 49(3):297-9. PubMed ID: 9291654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
